Mesuron Inc. is a US commercial company specializing in the development and fabrication of SQUID-based magnetometers for various applications, including MagnetoCardioGraphy (MCG), which is our main interest and the center of our attention. Superconducting Quantum Interference Devices (SQUIDs) known since early 1960-s are the most sensitive sensors of magnetic field. They are capable of measuring extremely weak magnetic signals from a beating heart, clearly distinguishing between healthy and diseased (ischemic) hearts. We have more than 30 years of extensive experience in developing such equipment, but only lately we have achieved a breakthrough in constructing magneto cardiographer that can reliably operate in any open, magnetically non-shielded environment, such as a typical hospital’s emergency room (ER), or intensive care unit (ICU). Before this breakthrough, diagnostic measurements in busy, magnetically noisy environments were either impossible or at least defective. Now, with Mesuron’s equipment, they became reliable and accurate. Measurements can be reliably made in close proximity to hospital elevators, all kinds of medical apparatus, moving metal beds, working printers, computers, etc. Needless to say, the magnetic environment in a typical private cardiology office is even more conducive to a smooth operation of our system. 

State of the art sensors, readout electronics and sophisticated software in our latest MCG system "Avalon-H90" makes a single (60-90 seconds), totally non-invasive measurement of time-dependent special distribution of the magnetic field over a patient’s torso (patient at rest on a bed), and from that single measurement it delivers valuable diagnostic result in 3-5 minutes -- the result that can be immediately interpreted by a doctor or by a technician.  This is done without any contact with the patient's body, without any kind of induced radiation, and without any injected pharmaceuticals. It is truly non-invasive. This became possible upon development of our proprietary, unique environmental magnetic interference (noise) reduction technology, said noise reduction built into the Mesuron magneto cardiograph, both in hardware and in software.  

Currently  Mesuron Inc. is making MCG systems for the R&D purposes. By customer request, we can certify such a system for safety with CE mark through UL testing and safety evaluation. Mesuron also has plans to have an FDA 510K (safety) approval for the MCG system "Avalon-H90". 

Clinical Value of Mesuron's MagnetoCardioGraphy


#1 Emergency Medicine - ER, ED and Chest Pain Units

Mesuron's MCG is providing a rapid noninvasive, no radiation, no contact, no pharmaceuticals test delivering results that could be used to rule-out low risk cardiac patients with chest pain admission with very high negative predictive value. It also delivers rapid result for chest pain patients having high risk Ventricle Repolarization Abnormalities (MI or ischemic cardiac events), with high positive predictive values. It also gives an indication for the low risk cardiac patients for further evaluation and follow up.